NYSE:CRI
Carter's Inc Stock News
$69.78
+0.660 (+0.95%)
At Close: May 16, 2024
Cimpress (CMPR) Q3 Earnings Miss Estimates, Revenues Beat
02:10pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Cimpress' (CMPR) third-quarter fiscal 2022 revenues gain from impressive performance across its segments.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
01:45pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should You Buy Carter's (CRI) Ahead of Earnings?
12:42pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Carter's (CRI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Should You Buy Carter's (CRI) Ahead of Earnings?
09:49am, Thursday, 28'th Apr 2022
Carter's (CRI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why BofA Downgrades Carter's Ahead Of Q1 Print
03:51pm, Wednesday, 27'th Apr 2022 Benzinga
Carter's, Inc. (NYSE: CRI) faces a risk to margins as the promotional environment normalizes, according to Bofa Securities.
The Carter's Analyst: Christopher Nardone downgraded the rating for Carter's
Here's How Carter's (CRI) Looks Just Ahead of Q1 Earnings
02:47pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Carter's (CRI) Q1 results are likely to reflect gains from solid demand and growth across channels and brands, offset by elevated transportation and compensation costs.
Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2022
02:02pm, Wednesday, 27'th Apr 2022 Benzinga
Upgrades
BTIG upgraded the previous rating for Acutus Medical Inc (NASDAQ:AFIB) from Neutral to Buy. In the fourth quarter, Acutus Medical showed an EPS of $1.00, compared to $0.89 from the year-ago
Where Carter's Stands With Analysts
01:02pm, Wednesday, 27'th Apr 2022 Benzinga
Analysts have provided the following ratings for Carter's (NYSE:CRI) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
1
2
1
0
Last 30D
Here's How Carter's (CRI) Looks Just Ahead of Q1 Earnings
12:18pm, Wednesday, 27'th Apr 2022
Carter's (CRI) Q1 results are likely to reflect gains from solid demand and growth across channels and brands, offset by elevated transportation and compensation costs.
Why BofA Downgrades Carter's Ahead Of Q1 Print
11:53am, Wednesday, 27'th Apr 2022
Carter's, Inc. (NYSE: CRI) faces a risk to margins as the promotional environment normalizes, according to Bofa Securities. The Carter's Analyst: Christopher Nardone downgraded the rating for Carter's
10 Biggest Price Target Changes For Wednesday
11:45am, Wednesday, 27'th Apr 2022 Benzinga
RBC Capital lowered General Motors Company (NYSE: GM) price target from $70 to $58. GM shares rose 1.9% to $38.75 in pre-market trading.
Wells Fargo raised the price target for Exelon Corporation
Will Carter's (CRI) Beat Estimates Again in Its Next Earnings Report?
01:32pm, Tuesday, 26'th Apr 2022
Carter's (CRI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
01:40pm, Monday, 25'th Apr 2022 Zacks Investment Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CRI vs. NKE: Which Stock Should Value Investors Buy Now?
03:40pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
CRI vs. NKE: Which Stock Is the Better Value Option?
CRI vs. NKE: Which Stock Should Value Investors Buy Now?
12:47pm, Wednesday, 20'th Apr 2022
CRI vs. NKE: Which Stock Is the Better Value Option?
